Chen VY, Siegfried LG, Tomic-Canic M, Stone RC, Pastar I
Theres people walking around that obviously do not have blonde hair yet they do

The pill may be a better starting point for patients who: Have a strong aversion to needles or self-injection Are earlier in their weight loss journey and want to establish habits before committing to injections Prefer a potentially lower-cost option without compromising clinical effectiveness Have a predictable morning routine that accommodates the empty-stomach dosing requirement Prefer not to deal with refrigeration or storage requirements The injection may be a better fit for patients who: Have an irregular schedule that makes consistent morning fasting difficult Take multiple daily oral medications that cannot be spaced 30 minutes from the semaglutide pill Have tried the pill and had suboptimal results due to adherence challenges Are seeking a once-weekly dosing schedule that requires less daily attention Have established cardiovascular disease and benefit from the broader outcomes data behind the injectable form The Frontiers in Endocrinology review noted that oral semaglutide may be especially useful in patients who decline injectable therapy, when injectable medications are unavailable, or as an initial therapy before transitioning to more potent treatment options

And then we saw these platforms, right after COVID, they started surging. Skinny Inc.: How will cheaper versions of Ozempic tip the scales
And with that growth comes something valuable for food and beverage manufacturers: a clearer picture of how consumers are adapting their eating and drinking behaviors
The Cultural Shift: From Medicine to Membership The GLP-1 boom didnt just create a new class of drugs it commercialized medicine itself, transforming clinical care into a subscription-based business built on vanity, virality, and venture-scale growth